Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Adults: A Six-Month Study

Publisher： Karger

E-ISSN： 1421-9832|205|3|271-277

ISSN： 1018-8665

Source： Dermatology, Vol.205, Iss.3, 2002-10, pp. : 271-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis

By  

Dermatology, Vol. 208, Iss. 4, 2004-06 ,pp. : 365-372

Karger

Access to resources Recommend Favorite

Belgian Observational Drug Utilization Study of Pimecrolimus Cream 1% in Routine Daily Practice in Atopic Dermatitis

By  

Dermatology, Vol. 217, Iss. 2, 2008-06 ,pp. : 156-163

Karger

Access to resources Recommend Favorite

Steroid-Sparing Effect of Pimecrolimus Cream 1% in Children with Severe Atopic Dermatitis

By  

Dermatology, Vol. 215, Iss. 4, 2007-10 ,pp. : 325-330

Karger

Access to resources Recommend Favorite

Percutaneous Absorption of Pimecrolimus Is Not Increased in Patients with Moderate to Severe Atopic Dermatitis when Pimecrolimus Cream 1% Is Applied under Occlusion

By  

Dermatology, Vol. 221, Iss. 4, 2010-11 ,pp. : 342-351

Karger

Access to resources Recommend Favorite

Clinical Management of Atopic Eczema with Pimecrolimus Cream 1% (Elidel®) in Paediatric Patients

By  

Dermatology, Vol. 215, Iss. 1, 2007-12 ,pp. : 3-17

Karger

Access to resources Recommend Favorite